middle.news
How Safe Is PYC-003? Early Data Suggests Promise for PKD Patients
3:43am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
How Safe Is PYC-003? Early Data Suggests Promise for PKD Patients
3:43am on Saturday 30th of August, 2025 AEST
Key Points
Positive safety and tolerability data from Phase 1a dose escalation study
No serious adverse events or kidney function abnormalities observed
PYC-003 targets Polycystic Kidney Disease by increasing PC1 protein expression
Phase 1b trials underway with plans for multiple ascending dose studies
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
PYC
OPEN ARTICLE